Human symbiont Bacteroides xylanisolvens attenuates NASH through intestinal nicotine catabolism
Chin J Nat Med
.
2023 Feb;21(2):81-82.
doi: 10.1016/S1875-5364(23)60387-5.
Authors
Haiming Hu
1
,
Ke Lan
1
,
Hongtao Liu
2
Affiliations
1
College of Basic Medical Sciences, Hubei University of Chinese Medicine, Wuhan 430065, China.
2
College of Basic Medical Sciences, Hubei University of Chinese Medicine, Wuhan 430065, China. Electronic address: hongtaoliu@hbtcm.edu.cn.
PMID:
36871984
DOI:
10.1016/S1875-5364(23)60387-5
No abstract available
Keywords:
Drug metabolism; Gut microbiota; Nicotine; Non-alcoholic fatty liver disease.
MeSH terms
Bacteroides
Humans
Nicotine*
Non-alcoholic Fatty Liver Disease*
Substances
Nicotine
Supplementary concepts
Bacteroides xylanisolvens